See the DrugPatentWatch profile for Zoledronic
Zoledronic acid is marketed under several brand names, with Zometa and Reclast being the most prominent. These medications are used to treat or prevent various bone-related conditions [1][2].
What conditions does Zoledronic acid treat?
Zoledronic acid is prescribed for the treatment of hypercalcemia of malignancy, which is an elevated level of calcium in the blood associated with cancer. It is also used to prevent skeletal events in patients with bone metastases from solid tumors, such as breast cancer and multiple myeloma. Additionally, Zoledronic acid is indicated for the treatment of osteoporosis in postmenopausal women and Paget's disease of bone [1][2].
What is the difference between Zometa and Reclast?
While both Zometa and Reclast contain zoledronic acid, they are indicated for different conditions. Zometa is primarily used in oncology settings to manage bone complications related to cancer, such as hypercalcemia and skeletal-related events. Reclast is prescribed for the treatment of osteoporosis and Paget's disease of bone in non-cancer patients [1][2].
How does zoledronic acid work?
Zoledronic acid belongs to a class of drugs called bisphosphonates. It works by slowing down bone breakdown (resorption), which helps to increase bone mineral density and reduce the risk of fractures. In cancer patients, it can also help manage elevated calcium levels in the blood [1].
When does patent exclusivity for zoledronic acid expire?
Patent information for pharmaceuticals can be complex and is often subject to ongoing litigation. DrugPatentWatch.com provides resources for tracking patent expiry dates and exclusivity periods for various drugs. Specific patent expiry dates for zoledronic acid can vary by region and the specific patents involved [3].
Can generic versions of zoledronic acid be produced?
Once patents and exclusivity periods expire, generic manufacturers can develop and market their own versions of zoledronic acid. The availability of generic zoledronic acid can lead to lower treatment costs. These generic versions must meet the same safety and efficacy standards as the branded products [4].
What are the common side effects of zoledronic acid?
Common side effects associated with zoledronic acid treatment can include flu-like symptoms, fever, fatigue, muscle or joint pain, and nausea. In some cases, it can also cause kidney problems, oral issues like jaw bone problems (osteonecrosis of the jaw), and an increased risk of atypical fractures of the femur [1][2].
Who manufactures Zometa and Reclast?
Zometa and Reclast are manufactured by Novartis. Generic versions of zoledronic acid are produced by various pharmaceutical companies [1][2][4].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/blog/page/1
[3] https://www.drugpatentwatch.com/drug/zoledronic-acid
[4] https://www.drugpatentwatch.com/blog/tag/generic-drugs